Electrovaya Inc. Announces Proposed Public Offering of Common Shares

Stock Information for Applied Dna Scie

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Applied Dna Scie

Electrovaya Announces date for Q4 and FY-2025 Financial Results & Conference Call
Electrovaya Provides a Business Update
Electrovaya to Participate in Three Investor Conferences
Electrovaya Inc. Announces Closing of Oversubscribed US$28.1 Million Public Offering of Common Shares, Including Full Exercise of Overallotment Option
Electrovaya Inc. Announces Pricing of Oversubscribed US$24.4 Million Public Offering of Common Shares
Electrovaya Expands Global Presence with New Japan Subsidiary to Support Growing Sales and Strategic Partnerships in Japan
Electrovaya ranked 3rd in Canada's Enterprise-Industry Leaders winners in Deloitte's Technology Fast 50TM program
Electrovaya Announces Estimated Preliminary Unaudited Q4 FY2025 Revenues at $20 million(1) and Full Year FY2025 Revenue at $64 million(1)

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.